Fiscal 2021 Second Quarter Highlights Net sales of $72.8 million increased 4.0% compared to the prior-year quarter Gross margin declined 410 basis…
Read More
AngioDynamics, with its disruptive and innovative medical devices, addresses unmet patient needs by elevating the standard of care for chronic and acute disease states in vascular, peripheral vascular, and oncology medicine.
These devices provide healthcare professionals around the world with the vital tools they need to deliver high-quality patient care and improve patient outcomes.
“The acquisition of Auryon brings a remarkable, foundational technology to our portfolio that will change the way caregivers deliver treatment…
The BioFlo PICC is the first PICC of its kind with Endexo Technology, providing a catheter more resistant to the…
The Solero* Microwave Tissue Ablation (MTA) System and Accessories are indicated for the ablation of soft tissue during open procedures….
It takes a team of talented people to become one of the world’s leading providers of innovative medical devices.
The deep commitment and contributions of our employees helped to build a global company that’s pioneering new ways to improve patient outcomes.
If you find the idea of joining a dynamic team that’s dedicated to improving the lives of patients appealing, we invite you to review our available opportunities.
"Our Dynamic People" spotlights the impressive talent helping drive our commitment to providing patients around the world with solutions that deliver high-quality care, wellness, & cures to live healthier, happier lives. This month, we are proud to highlight Anna Tamas!
#FacesBehindTheCases honoring the incredible physicians and teams that improve patients’ lives with the use of the #AngioVac system. Today we celebrate @Kasi_vascular and his team at @ValleyCare_VHS on a successful #RightAtrium case. https://bit.ly/AVRiskInfo
Getting it RIGHT means getting it all at once. #AngioVac maintains vacuum without interruption, minimizing the risk of #CIT embolization. Our proprietary funnel tip allows for en bloc removal, decreasing fragmentation of clot. #ClotPioneers #TwitterIR https://bit.ly/AVRiskInfo
Getting it RIGHT (again) in 2021. #AngioVac is proud to offer clinicians a safe, effective technology for removing thrombus material from the right atrium since 2015. Successful cases need the RIGHT device with a track record of positive outcomes(1) in the RIGHT atrium.
AngioDynamics® history is best characterized by innovation and growth. Originally founded in Queensbury, N.Y., U.S., in 1988, AngioDynamics has grown into a NASDAQ-listed public company with a global reach.
Latham, NY (HQ)
Glens Falls, NY (Manufacturing)
Queensbury, NY (Manufacturing)
Marlborough, MA (R&D)
Amsterdam, NL (International HQ)
São Paulo, BR (Brazil Office)
Oakville, CA (Canada Office)
Hong Kong, HK (Asia Pacific Regional Office)
Rehovot, IL (Israel Office)
